ReviewCancer letters2016
Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
Tang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewCancer letters2016
Tang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.